Human Papillomavirus Vaccination in Saudi Arabia: A Narrative Review of Current Evidence
Human papillomavirus (HPV) represents the most common sexually transmitted infection globally, exerting a substantial impact on sexual and reproductive health, with a high oncogenic potential leading to various malignancies. The prevalence of HPV in Saudi Arabia ranges from 9% to 43%, with types 16,...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-12-01
|
| Series: | Journal of Pharmacy and Bioallied Sciences |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/jpbs.jpbs_798_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850195404920979456 |
|---|---|
| author | Abdulrahman M. M. Alqahtani Mohammed S. S. Alshahrani Ebtesam Almajed Rawan A. Bin Salamah Norah Alqntash Amina M. Biju Mohima S. Meem Fawaz Pullishery |
| author_facet | Abdulrahman M. M. Alqahtani Mohammed S. S. Alshahrani Ebtesam Almajed Rawan A. Bin Salamah Norah Alqntash Amina M. Biju Mohima S. Meem Fawaz Pullishery |
| author_sort | Abdulrahman M. M. Alqahtani |
| collection | DOAJ |
| description | Human papillomavirus (HPV) represents the most common sexually transmitted infection globally, exerting a substantial impact on sexual and reproductive health, with a high oncogenic potential leading to various malignancies. The prevalence of HPV in Saudi Arabia ranges from 9% to 43%, with types 16, 18, and 45 being the most common high-risk strains. Despite the availability of effective vaccines such as Gardasil 9, Gardasil, and Cervarix, proper awareness and vaccination rates remain low in Saudi Arabia. Only 4% of the population has received the HPV vaccine. The Saudi Ministry of Health has integrated HPV vaccines into the national immunization schedule, offering them free of charge and ensuring their availability for adolescent girls and women. However, challenges persist, including cultural and religious beliefs, inadequate healthcare infrastructure, and insufficient public awareness. To effectively increase HPV vaccination coverage, it is crucial to implement comprehensive public education campaigns, actively involve healthcare professionals, and address cultural and religious concerns with sensitivity and respect. International collaboration, such as initiatives by the Gavi alliance and sustained research efforts, is critical to optimizing HPV vaccine efficacy, accessibility, and uptake. Through coordinated efforts, the global burden of HPV-related diseases can be significantly reduced, ultimately leading to improved public health outcomes. |
| format | Article |
| id | doaj-art-3e05ecd4e40b46d6b56ccf265ff11280 |
| institution | OA Journals |
| issn | 0976-4879 0975-7406 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Journal of Pharmacy and Bioallied Sciences |
| spelling | doaj-art-3e05ecd4e40b46d6b56ccf265ff112802025-08-20T02:13:45ZengWolters Kluwer Medknow PublicationsJournal of Pharmacy and Bioallied Sciences0976-48790975-74062024-12-0116Suppl 5S4201S420410.4103/jpbs.jpbs_798_24Human Papillomavirus Vaccination in Saudi Arabia: A Narrative Review of Current EvidenceAbdulrahman M. M. AlqahtaniMohammed S. S. AlshahraniEbtesam AlmajedRawan A. Bin SalamahNorah AlqntashAmina M. BijuMohima S. MeemFawaz PullisheryHuman papillomavirus (HPV) represents the most common sexually transmitted infection globally, exerting a substantial impact on sexual and reproductive health, with a high oncogenic potential leading to various malignancies. The prevalence of HPV in Saudi Arabia ranges from 9% to 43%, with types 16, 18, and 45 being the most common high-risk strains. Despite the availability of effective vaccines such as Gardasil 9, Gardasil, and Cervarix, proper awareness and vaccination rates remain low in Saudi Arabia. Only 4% of the population has received the HPV vaccine. The Saudi Ministry of Health has integrated HPV vaccines into the national immunization schedule, offering them free of charge and ensuring their availability for adolescent girls and women. However, challenges persist, including cultural and religious beliefs, inadequate healthcare infrastructure, and insufficient public awareness. To effectively increase HPV vaccination coverage, it is crucial to implement comprehensive public education campaigns, actively involve healthcare professionals, and address cultural and religious concerns with sensitivity and respect. International collaboration, such as initiatives by the Gavi alliance and sustained research efforts, is critical to optimizing HPV vaccine efficacy, accessibility, and uptake. Through coordinated efforts, the global burden of HPV-related diseases can be significantly reduced, ultimately leading to improved public health outcomes.https://journals.lww.com/10.4103/jpbs.jpbs_798_24cervical cancerpreventionvaccineviral infection |
| spellingShingle | Abdulrahman M. M. Alqahtani Mohammed S. S. Alshahrani Ebtesam Almajed Rawan A. Bin Salamah Norah Alqntash Amina M. Biju Mohima S. Meem Fawaz Pullishery Human Papillomavirus Vaccination in Saudi Arabia: A Narrative Review of Current Evidence Journal of Pharmacy and Bioallied Sciences cervical cancer prevention vaccine viral infection |
| title | Human Papillomavirus Vaccination in Saudi Arabia: A Narrative Review of Current Evidence |
| title_full | Human Papillomavirus Vaccination in Saudi Arabia: A Narrative Review of Current Evidence |
| title_fullStr | Human Papillomavirus Vaccination in Saudi Arabia: A Narrative Review of Current Evidence |
| title_full_unstemmed | Human Papillomavirus Vaccination in Saudi Arabia: A Narrative Review of Current Evidence |
| title_short | Human Papillomavirus Vaccination in Saudi Arabia: A Narrative Review of Current Evidence |
| title_sort | human papillomavirus vaccination in saudi arabia a narrative review of current evidence |
| topic | cervical cancer prevention vaccine viral infection |
| url | https://journals.lww.com/10.4103/jpbs.jpbs_798_24 |
| work_keys_str_mv | AT abdulrahmanmmalqahtani humanpapillomavirusvaccinationinsaudiarabiaanarrativereviewofcurrentevidence AT mohammedssalshahrani humanpapillomavirusvaccinationinsaudiarabiaanarrativereviewofcurrentevidence AT ebtesamalmajed humanpapillomavirusvaccinationinsaudiarabiaanarrativereviewofcurrentevidence AT rawanabinsalamah humanpapillomavirusvaccinationinsaudiarabiaanarrativereviewofcurrentevidence AT norahalqntash humanpapillomavirusvaccinationinsaudiarabiaanarrativereviewofcurrentevidence AT aminambiju humanpapillomavirusvaccinationinsaudiarabiaanarrativereviewofcurrentevidence AT mohimasmeem humanpapillomavirusvaccinationinsaudiarabiaanarrativereviewofcurrentevidence AT fawazpullishery humanpapillomavirusvaccinationinsaudiarabiaanarrativereviewofcurrentevidence |